Further mechanistic studies of the OTUD5-induced cancer-promoting effects revealed that OTUD5 regulates mTOR signaling through the OTUD5-RNF186-sestrin2-mTOR axis in bladder cancer. This evidence concerns the gene RNF186 and urinary bladder carcinoma.